Bioventus INC Form 4 insider transactions

A Bioventus Inc. executive, Anthony D'Adamio, sold 5,848 shares of Class A Common Stock to cover taxes after restricted stock units vested.

Bioventus Inc.'s SVP & CFO, Mark Singleton, acquired 31,000 shares of Class A Common Stock through the vesting of restricted stock units.

Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., reports the acquisition of 8,600 shares of Class A Common Stock due to the vesting of Restricted Stock Units (RSUs).

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., reports the acquisition of 19,850 shares of Class A Common Stock and the disposition of 19,850 Restricted Stock Units on December 20, 2024.

John A. Bartholdson, a director and 10% owner of Bioventus Inc., reports the acquisition of additional Class A Common Stock through indirect ownership.

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., sold 9,219 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 5,904 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., sold 2,559 shares of Class A Common Stock to cover taxes upon vesting of restricted stock units.

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting of restricted stock units and subsequent acquisition of Class A Common Stock.

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., exercised stock options and received restricted stock units, resulting in changes to his beneficial ownership of the company's Class A Common Stock.

Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., reports the acquisition of 8,600 shares of Class A Common Stock and corresponding Restricted Stock Units on June 20, 2024.

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., sold 13,753 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 11,308 shares of Class A Common Stock on June 17, 2024, to cover taxes upon the vesting of restricted stock units.

Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., sold 8,759 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Director Michelle McMurry-Heath reports the vesting of 386 shares of Bioventus Inc. Class A Common Stock on June 16, 2024.

Director Mary Kay Ladone reports the vesting of 1,814 restricted stock units into Class A Common Stock of Bioventus Inc.

Director Pat Beyer reports the vesting of 965 Class A Common Stock shares at Bioventus Inc.

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the vesting and subsequent disposal of restricted stock units on June 15, 2024.

Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., exercised stock options and converted restricted stock units into Class A Common Stock on June 15, 2024.

Katrina J. Church, SVP & Chief Compliance Officer of Bioventus Inc., reports the vesting and subsequent disposal of restricted stock units on June 15, 2024.

Director Martin P. Sutter acquired 26,493 restricted stock units of Bioventus Inc. on June 11, 2024.

Director Susan M. Stalnecker reports the acquisition of 26,493 Restricted Stock Units (RSUs) in Bioventus Inc. on June 11, 2024.

Director Guy P. Nohra reports acquisition of 26,493 Restricted Stock Units (RSUs) in Bioventus Inc. on June 11, 2024.

Director Neels Guido J acquired 26,493 Restricted Stock Units (RSUs) in Bioventus Inc. on June 11, 2024, according to a Form 4 filing.

Director McMurry-Heath Michelle acquired 26,493 Restricted Stock Units (RSUs) of Bioventus Inc. on June 11, 2024.

Director Mary Kay Ladone acquired 26,493 restricted stock units (RSUs) of Bioventus Inc. on June 11, 2024, which will vest on the earlier of the next annual meeting or the first anniversary of the grant date.

Director William A. Hawkins acquired 26,493 Restricted Stock Units (RSUs) of Bioventus Inc. on June 11, 2024, which will vest on the earlier of the next annual meeting or the first anniversary of the grant date.

Director Pat Beyer acquired 26,493 Restricted Stock Units (RSUs) of Bioventus Inc. on June 11, 2024, which will vest on the earlier of the next annual meeting or the first anniversary of the grant date.

Director John A. Bartholdson acquired 26,493 Restricted Stock Units (RSUs) of Bioventus Inc. on June 11, 2024, which will vest on the earlier of the next annual meeting or the first anniversary of the grant date.

Director Martin P. Sutter reports the vesting and conversion of restricted stock units into Class A Common Stock of Bioventus Inc.